跳至主要内容
临床试验/CTRI/2020/08/027436
CTRI/2020/08/027436尚未招募2 期

A comparative study of shatpushpa taila (nasya and matrabasti) along with tilamooladi churan in the managment of pushpaghni wsr to polycystic ovarian syndrome

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年5月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Improvement in signs and symptoms of patients

研究概览

简要总结

A randomised controlled trial in which 15 Patients will receive Shatpushpa taila Nasya with tilamooladi churna and 15 Patients will receive Shatpushpa taila Matrabasti along with Tilamooladi Churna suffering form Polycystic Ovarian Syndrome

研究设计

研究类型
Interventional
分配方式
Adaptive randomization, such as minimization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Fullfill at least 2 of the following:- 1.Oligomenorrhea and/or anovulation 2.Hyperandonism (Clinical and/or bio-chemical) 3.PCOS-Diagnosed by Trans Vaginal Sonography (TVS In married)and USG Abdomen in unmarried.

排除标准

  • •Any other cause of oligomenorrhea and anovulation excluding PCOD.
  • •Any organic lesion like adrenal or ovarian.
  • •Congenital anomalies and any other pelvic pathology.
  • •Patients having STDs.

结局指标

主要结局

Improvement in signs and symptoms of patients

时间窗: 2 months

Oligomenorrhea,Hypomenorrhea, Dysmenorrhoea,Menorrhagia

时间窗: 2 months

次要结局

  • Efficacy of the medicine on(Obesity,Acne, Hirsutism)

研究者

发起方
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验